FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pyxis Oncology's Free Cash Flow for the
three
months ended in Dec. 2023 was $-15.25 Mil. Pyxis Oncology's Revenue for the
three
months ended in Dec. 2023 was $0.00 Mil. Therefore, Pyxis Oncology's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.
As of today, Pyxis Oncology's current FCF Yield % is -28.40%.
The historical rank and industry rank for Pyxis Oncology's FCF Margin % or its related term are showing as below:
PYXS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -149.715 * Ranked among companies with meaningful FCF Margin % only.
Pyxis Oncology FCF Margin % Historical Data
The historical data trend for Pyxis Oncology's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Pyxis Oncology Annual Data
Trend
Dec19
Dec20
Dec21
Dec22
Dec23
FCF Margin %
-
-
-
-
-
Pyxis Oncology Quarterly Data
Dec19
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
FCF Margin %
-
-
-
-
-
Competitive Comparison
For the Biotechnology subindustry, Pyxis Oncology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pyxis Oncology FCF Margin % Distribution
For the Biotechnology industry and Healthcare sector, Pyxis Oncology's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Pyxis Oncology's FCF Margin % falls into.
Pyxis Oncology FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Pyxis Oncology's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pyxis Oncology FCF Margin % Related Terms
Thank you for viewing the detailed overview of Pyxis Oncology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Pyxis Oncology (Pyxis Oncology) Business Description
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve the quality of life for patients. It develops the product candidates to directly kill tumor cells and address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Its lead ADC product candidate is PYX-201, an investigational human IgG1 isotype site-specifically conjugated with an auristatin toxin targeting EDB that initially develop for solid tumors, including NSCLC, hormone receptor-positive breast, ovarian and thyroid cancer. The IO product candidate is PYX-106, designed to block Siglec-15-mediated suppression of T-cell proliferation and function.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PYXS has been successfully added to your 